Literature DB >> 19443577

Endotoxin-induced growth hormone resistance in skeletal muscle.

Yu Chen1, Sumita Sood, Vidya M R Krishnamurthy, Peter Rotwein, Ralph Rabkin.   

Abstract

Inflammation-induced skeletal muscle wasting is a serious clinical problem and arises in part because of resistance to GH-stimulated IGF-I expression. Although it is established that in the liver, resistance develops because of impaired signaling through the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) transduction pathway, together with a more distal defect in STAT5 DNA-binding activity, the situation in skeletal muscle is unclear. Accordingly, we set out to characterize the mechanisms behind the skeletal muscle resistance to GH in rats with acute inflammation induced by endotoxin. Endotoxin caused significant declines in GH-stimulated STAT5a/b phosphorylation and IGF-I gene expression, and this occurred despite a lack of change in signaling protein levels or phosphorylation of JAK2. In whole muscle, GH-stimulated phospho-STAT5a/b levels were reduced by half, and in the nucleus, phospho-STAT5b levels were similarly reduced. Furthermore, the binding of phosphorylated STAT5b to DNA was reduced and to a similar extent to the reduction in nuclear phosphorylated STAT5b. Interestingly, GH-induced androgen receptor gene expression was also suppressed. Thus, it appears that skeletal muscle resistance to GH-stimulated IGF-I expression in acute endotoxemia arises from a defect in STAT5b signaling, with a proportionate reduction in STAT5b DNA binding. Finally, it appears that resistance to GH-induced androgen receptor expression also develops and, together with the attenuated GH-induced IGF-I expression, likely plays an important role in the muscle wasting that arises in endotoxin-induced inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443577      PMCID: PMC2717874          DOI: 10.1210/en.2008-1703

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  32 in total

Review 1.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 2.  Diabetes and suppressors of cytokine signaling proteins.

Authors:  Sif G Rønn; Nils Billestrup; Thomas Mandrup-Poulsen
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

3.  Tumor necrosis factor inhibits growth hormone-mediated gene expression in hepatocytes.

Authors:  Tamer Ahmed; Gladys Yumet; Margaret Shumate; Charles H Lang; Peter Rotwein; Robert N Cooney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-03-30       Impact factor: 4.052

4.  Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.

Authors:  Yu Chen; Difei Sun; Vidya M R Krishnamurthy; Ralph Rabkin
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-02-27       Impact factor: 4.310

Review 5.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Authors:  Ralph Rabkin; Di Fei Sun; Yu Chen; Jane Tan; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

Review 6.  Negative regulation of growth hormone receptor signaling.

Authors:  Amilcar Flores-Morales; Christopher J Greenhalgh; Gunnar Norstedt; Elizabeth Rico-Bautista
Journal:  Mol Endocrinol       Date:  2005-07-21

7.  Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.

Authors:  Gladys Yumet; Margaret L Shumate; D Patrick Bryant; Charles H Lang; Robert N Cooney
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

Review 8.  New insights into growth hormone action.

Authors:  M J Waters; H N Hoang; D P Fairlie; R A Pelekanos; R J Brown
Journal:  J Mol Endocrinol       Date:  2006-02       Impact factor: 5.098

Review 9.  Regulation of muscle protein synthesis during sepsis and inflammation.

Authors:  Charles H Lang; Robert A Frost; Thomas C Vary
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-05-15       Impact factor: 4.310

Review 10.  Recent advances in growth hormone signaling.

Authors:  Nathan J Lanning; Christin Carter-Su
Journal:  Rev Endocr Metab Disord       Date:  2006-12       Impact factor: 9.306

View more
  1 in total

Review 1.  Links between growth hormone and aging.

Authors:  Andrzej Bartke; Reyhan Westbrook; Liou Sun; Mariusz Ratajczak
Journal:  Endokrynol Pol       Date:  2013       Impact factor: 1.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.